Digital transformation maximizes lab automation impact
With smarter tools, AI-powered insights, and a focus on user experience, lab automation is becoming more accessible, flexible, and impactful than ever
With smarter tools, AI-powered insights, and a focus on user experience, lab automation is becoming more accessible, flexible, and impactful than ever
From synthetic biology to microbiome and food safety research, the QPix FLEX system gives researchers the power to accelerate discovery, reduce hands-on time, and streamline their entire microbial screening process
Designed to enable scientists to conduct small-scale experiments quickly and affordably
Dr. Chia-Lin Wei, Professor of Genome Sciences at University of Washington, shares how to unlock DNA methylation insights for neuroscience and cancer research
Data to be presented as a late-breaking abstract at the 2025 European Society for Medical Oncology (ESMO) Breast Cancer Congress
As scientists uncover more links between gut bacteria and cancer, microbiome testing offers a promising approach to detect, treat, and even prevent the disease
A study by Karl Landsteiner University of Health Sciences shows that higher radiation doses in lung cancer treatment carry no added risk of inflammation and may improve survival
Laboratory water quality is often overlooked but plays a pivotal role in ensuring accuracy, compliance, and reproducibility
Hear how researchers have discovered a new cellular mechanism that controls the stability of messenger RNA (mRNA) in cells
New solutions support high-precision analytics for process development, batch release and regulatory compliance and enable a standardized workflow
1 in 3 Phase II trials were terminated in 2024
The UG 100 offers a cost-effective and extremely low-error sequencing profile
By developing rapid, accurate, and cost-effective lateral flow tests for prostate cancer, Valley Diagnostics aims to make early diagnosis more accessible and reliable
Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate 'A Festival of Life Science'
The Adeno-Associated Virus will be used in a Phase 1 trial in patients with advanced, high-risk acute myeloid leukemia.
Hear expert insights on ADC innovations, manufacturing challenges, and the future of precision medicine
New test format enhances commercialisation potential
Since 2021, only 14% of rivers in England achieved ‘good’ ecological status and none received an overall ‘good’ classification from the Environment Agency
Technology advances, coupled with collaborations between equipment makers and healthcare organizations, are improving early detection of blood cancers in Africa
Redipor by AnalytiChem combining 150+ years of expertise in high-quality prepared media, now manufactured in three production facilities worldwide
With intuitive workflows, quick setup, and expert support, Veya is making automation accessible and cost-effective for first-time users
Combining Singleron’s innovation in single-cell technologies with Hamilton’s expertise in laboratory automation, Tensor streamlines the single-cell sequencing process